AMPICILLIN

AMPICILLIN was reported 8310 times

AMPICILLIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 122 0.8714
1 CONGENITAL CLAVICULAR AGENESIS 8 0.6667
2 NEONATAL CANDIDA INFECTION 18 0.4186
3 CONGENITAL LYMPHOEDEMA 7 0.4118
4 UMBILICAL ERYTHEMA 14 0.2295
5 DELIVERY 126 0.1912
6 MENINGITIS CANDIDA 13 0.1857
7 PERIUMBILICAL ABSCESS 8 0.1194
8 ACQUIRED FACTOR V DEFICIENCY 13 0.1182
9 CONGENITAL CYSTIC LUNG 13 0.1083
10 LONG QT SYNDROME CONGENITAL 9 0.1000
11 PREMATURE BABY DEATH 8 0.0976
12 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 19 0.0931
13 NEONATAL CARDIAC FAILURE 8 0.0889
14 LISTERIA ENCEPHALITIS 10 0.0877
15 CARDIAC VALVE ABSCESS 8 0.0860
16 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 37 0.0761
17 ENCEPHALITIS BRAIN STEM 13 0.0751
18 KIDNEY DUPLEX 18 0.0750
19 ATELECTASIS NEONATAL 8 0.0741
20 THERAPEUTIC PRODUCT CROSS-REACTIVITY 61 0.0683
21 SEPSIS NEONATAL 49 0.0603
22 CONDUCTIVE DEAFNESS 18 0.0561
23 AMNIOTIC CAVITY INFECTION 40 0.0553
24 FEVER NEONATAL 7 0.0534
25 THYMUS DISORDER 10 0.0524
26 CARDIAC ARREST NEONATAL 7 0.0507
27 VITAMIN K DEFICIENCY 20 0.0498
28 NEONATAL RESPIRATORY FAILURE 24 0.0474
29 CATHETER SITE ABSCESS 8 0.0460
30 LISTERIOSIS 50 0.0452
31 MONOCYTOSIS 28 0.0451
32 NECROTISING ENTEROCOLITIS NEONATAL 17 0.0419
33 NEONATAL INFECTION 14 0.0405
34 THROMBOCYTOPENIA NEONATAL 17 0.0404
35 PLEOCYTOSIS 22 0.0378
36 HYDROPS FOETALIS 23 0.0375
37 TYPE IV HYPERSENSITIVITY REACTION 100 0.0365
38 FACTOR V INHIBITION 7 0.0361
39 LISTERIA SEPSIS 9 0.0341
40 HEPATIC INFARCTION 12 0.0318
41 MORGANELLA INFECTION 9 0.0307
42 NEONATAL DISORDER 48 0.0303
43 JARISCH-HERXHEIMER REACTION 21 0.0295
44 CONGENITAL SKIN DIMPLES 7 0.0290
45 LARYNGEAL STENOSIS 16 0.0277
46 NEONATAL HYPOTENSION 10 0.0272
47 DOUBLE OUTLET RIGHT VENTRICLE 8 0.0271
48 BRADYCARDIA NEONATAL 34 0.0270
49 ANAEMIA NEONATAL 13 0.0270
50 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 14 0.0267
51 PULMONARY ARTERY STENOSIS 10 0.0255
52 MENINGITIS LISTERIA 13 0.0255
53 POLYHYDRAMNIOS 25 0.0245
54 DEATH NEONATAL 34 0.0244
55 CEREBRAL PALSY 23 0.0242
56 NEONATAL HYPOXIA 20 0.0242
57 BRONCHOPULMONARY DYSPLASIA 19 0.0236
58 RETINOPATHY OF PREMATURITY 13 0.0235
59 HYPERBILIRUBINAEMIA NEONATAL 13 0.0223
60 NEONATAL RESPIRATORY DISTRESS 21 0.0223
61 CARDIAC SEPTAL DEFECT 16 0.0223
62 NEONATAL TACHYPNOEA 9 0.0218
63 APGAR SCORE LOW 28 0.0217
64 CNS VENTRICULITIS 7 0.0215
65 PERSISTENT FOETAL CIRCULATION 13 0.0213
66 PREMATURE DELIVERY 338 0.0212
67 NECROTISING COLITIS 26 0.0205
68 NEONATAL RESPIRATORY DISTRESS SYNDROME 72 0.0203
69 SYSTEMIC CANDIDA 51 0.0203
70 TACHYCARDIA FOETAL 10 0.0200
71 LOW BIRTH WEIGHT BABY 159 0.0200
72 MECONIUM IN AMNIOTIC FLUID 7 0.0199
73 ANISOCYTOSIS 13 0.0198
74 INFANTILE APNOEA 16 0.0196
75 FOETAL HEART RATE DECREASED 12 0.0192
76 PATENT DUCTUS ARTERIOSUS 76 0.0191
77 CARDIAC VALVE VEGETATION 9 0.0185
78 INTRAVENTRICULAR HAEMORRHAGE 45 0.0181
79 CERVICAL INCOMPETENCE 9 0.0177
80 JOINT CONTRACTURE 19 0.0177
81 BLADDER TRANSITIONAL CELL CARCINOMA 25 0.0174
82 RESPIRATORY DISORDER NEONATAL 28 0.0173
83 NUTRITIONAL CONDITION ABNORMAL 12 0.0172
84 PREMATURE BABY 512 0.0170
85 FUNGAEMIA 26 0.0165
86 CITROBACTER INFECTION 7 0.0163
87 ENTEROCOCCAL SEPSIS 13 0.0160
88 ENTEROCOCCAL BACTERAEMIA 17 0.0160
89 BACILLUS INFECTION 10 0.0158
90 SYNDACTYLY 13 0.0156
91 ENTEROCOCCUS TEST POSITIVE 10 0.0154
92 KLEBSIELLA TEST POSITIVE 10 0.0154
93 PREMATURE RUPTURE OF MEMBRANES 36 0.0149
94 PANCREATIC PSEUDOCYST 11 0.0142
95 EXPOSURE TO SARS-COV-2 24 0.0141
96 RENAL TUBULAR INJURY 17 0.0140
97 LARGE FOR DATES BABY 12 0.0136
98 WEST NILE VIRAL INFECTION 10 0.0133
99 PRIMARY SEQUESTRUM 12 0.0132
100 MATERNAL EXPOSURE DURING DELIVERY 13 0.0131
101 NEONATAL ASPHYXIA 9 0.0127
102 DRY GANGRENE 8 0.0126
103 OPISTHOTONUS 10 0.0126
104 STENOTROPHOMONAS INFECTION 17 0.0125
105 FEEDING DISORDER NEONATAL 13 0.0124
106 ACINETOBACTER INFECTION 13 0.0119
107 BICUSPID AORTIC VALVE 7 0.0118
108 FUSARIUM INFECTION 8 0.0114
109 FOETAL HEART RATE DECELERATION ABNORMALITY 8 0.0113
110 RESPIRATORY ACIDOSIS 44 0.0112
111 CANDIDA SEPSIS 10 0.0111
112 LIP EROSION 8 0.0110
113 HYPOTONIA NEONATAL 17 0.0109
114 DEVELOPMENTAL HIP DYSPLASIA 9 0.0108
115 NEPHROGENIC ANAEMIA 50 0.0108
116 BRAIN ABSCESS 27 0.0107
117 ENTEROCOCCAL INFECTION 51 0.0105
118 STRONGYLOIDIASIS 17 0.0105
119 PATHOGEN RESISTANCE 95 0.0104
120 PREMATURE SEPARATION OF PLACENTA 16 0.0104
121 REBOUND ACID HYPERSECRETION 31 0.0102
122 QUADRIPARESIS 17 0.0102
123 PRETERM PREMATURE RUPTURE OF MEMBRANES 12 0.0100
124 ATRIAL SEPTAL DEFECT 83 0.0099
125 PSEUDOMEMBRANOUS COLITIS 22 0.0098
126 PANCREATITIS RELAPSING 8 0.0098
127 OTITIS MEDIA 32 0.0097
128 SKIN TEST POSITIVE 9 0.0096
129 GLOMERULONEPHRITIS MINIMAL LESION 7 0.0096
130 DIPLEGIA 19 0.0096
131 ESCHAR 7 0.0096
132 HEMIANOPIA HOMONYMOUS 7 0.0095
133 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0095
134 HYPOPERFUSION 10 0.0095
135 ULCERATIVE KERATITIS 26 0.0095
136 HYPOGLYCAEMIA NEONATAL 15 0.0093
137 ARTHRITIS INFECTIVE 42 0.0090
138 HYPOGONADISM 9 0.0089
139 RIGHT VENTRICULAR HYPERTROPHY 8 0.0089
140 MACROCYTOSIS 10 0.0086
141 HAEMORRHAGIC DIATHESIS 30 0.0084
142 HYPERPARATHYROIDISM SECONDARY 21 0.0084
143 ACTINOMYCOSIS 8 0.0084
144 ESCHERICHIA TEST POSITIVE 10 0.0083
145 LIVER ABSCESS 27 0.0083
146 PULMONARY HAEMORRHAGE 65 0.0083
147 COARCTATION OF THE AORTA 8 0.0083
148 MENINGITIS ASEPTIC 37 0.0082
149 NOCARDIOSIS 21 0.0082
150 FOETAL EXPOSURE DURING PREGNANCY 658 0.0081
151 TALIPES 25 0.0080
152 VENTRICULAR SEPTAL DEFECT 46 0.0080
153 JAUNDICE NEONATAL 15 0.0079
154 CEREBRAL VENTRICLE DILATATION 9 0.0078
155 ENDOCARDITIS 40 0.0078
156 MENINGITIS BACTERIAL 11 0.0077
157 RENAL INFARCT 11 0.0076
158 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 7 0.0076
159 KLEBSIELLA INFECTION 38 0.0075
160 METABOLIC ALKALOSIS 12 0.0075
161 MENINGITIS CRYPTOCOCCAL 13 0.0074
162 PREMATURE LABOUR 41 0.0072
163 STILLBIRTH 35 0.0072
164 CLEFT LIP AND PALATE 8 0.0072
165 IDIOSYNCRATIC DRUG REACTION 7 0.0071
166 GENERALISED ANXIETY DISORDER 10 0.0068
167 CLOSTRIDIUM DIFFICILE COLITIS 71 0.0067
168 LINEAR IGA DISEASE 11 0.0066
169 VENTRICULAR DYSFUNCTION 17 0.0065
170 ENTEROBACTER INFECTION 11 0.0065
171 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 7 0.0065
172 INTRA-ABDOMINAL HAEMATOMA 8 0.0065
173 ASPERGILLUS INFECTION 42 0.0064
174 BREECH PRESENTATION 8 0.0064
175 LEFT ATRIAL DILATATION 8 0.0063
176 HYDROCEPHALUS 34 0.0062
177 DILATATION VENTRICULAR 13 0.0062
178 FOETAL DISTRESS SYNDROME 13 0.0061
179 ENCEPHALITIS 42 0.0061
180 APPETITE DISORDER 40 0.0060
181 MATERNAL EXPOSURE DURING PREGNANCY 537 0.0060
182 PNEUMONIA KLEBSIELLA 11 0.0060
183 DYSMORPHISM 14 0.0059
184 POSTPARTUM HAEMORRHAGE 8 0.0059
185 MENINGITIS 39 0.0058
186 OLIGURIA 36 0.0058
187 FOETAL DEATH 30 0.0058
188 APNOEA 45 0.0058
189 MUCORMYCOSIS 15 0.0058
190 CANDIDA INFECTION 97 0.0057
191 DYSPHORIA 29 0.0057
192 OSTEOSCLEROSIS 9 0.0057
193 TUBULOINTERSTITIAL NEPHRITIS 106 0.0057
194 APLASIA 11 0.0056
195 END STAGE RENAL DISEASE 102 0.0056
196 CLOSTRIDIUM TEST POSITIVE 12 0.0054
197 HYPOTONIA 54 0.0054
198 OLIGOHYDRAMNIOS 18 0.0054
199 SALMONELLOSIS 9 0.0053
200 RENAL COLIC 12 0.0053
201 LIVEDO RETICULARIS 11 0.0053
202 BLOOD PH DECREASED 9 0.0053
203 PANCREATIC CYST 10 0.0052
204 BRADYPNOEA 14 0.0052
205 VENTRICULAR HYPERTROPHY 13 0.0052
206 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
207 LEUKOCYTOSIS 91 0.0050
208 CLOSTRIDIAL INFECTION 17 0.0050
209 BACTERIAL SEPSIS 16 0.0049
210 CEREBELLAR HAEMORRHAGE 7 0.0049
211 RASH MACULO-PAPULAR 109 0.0049
212 BLOOD PRESSURE SYSTOLIC ABNORMAL 12 0.0049
213 SYSTEMIC INFECTION 8 0.0048
214 ENTEROCOLITIS HAEMORRHAGIC 7 0.0047
215 RASH MORBILLIFORM 13 0.0047
216 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 120 0.0047
217 INFLAMMATORY MARKER INCREASED 23 0.0046
218 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0046
219 FANCONI SYNDROME ACQUIRED 8 0.0046
220 HEART DISEASE CONGENITAL 16 0.0045
221 MEGACOLON 7 0.0045
222 MATERNAL DRUGS AFFECTING FOETUS 34 0.0044
223 CHEST INJURY 9 0.0043
224 OTOTOXICITY 8 0.0043
225 HYPERCAPNIA 13 0.0043
226 PSEUDOMONAS INFECTION 37 0.0043
227 TRICUSPID VALVE INCOMPETENCE 34 0.0043
228 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
229 INTERVERTEBRAL DISCITIS 8 0.0042
230 ATELECTASIS 41 0.0042
231 MULTIPLE-DRUG RESISTANCE 13 0.0042
232 LIVE BIRTH 35 0.0042
233 EXPOSED BONE IN JAW 9 0.0041
234 CEREBELLAR SYNDROME 9 0.0041
235 DRUG RESISTANCE 105 0.0041
236 BACTERAEMIA 48 0.0040
237 AORTIC VALVE INCOMPETENCE 17 0.0040
238 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 31 0.0040
239 TYPE I HYPERSENSITIVITY 14 0.0040
240 METASTASES TO MENINGES 9 0.0040
241 SKIN WARM 23 0.0039
242 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111 0.0039
243 IMMUNE-MEDIATED HEPATITIS 8 0.0039
244 HEPATOSPLENOMEGALY 10 0.0039
245 METHAEMOGLOBINAEMIA 9 0.0039
246 HAEMOLYTIC URAEMIC SYNDROME 9 0.0039
247 CAPILLARY LEAK SYNDROME 8 0.0039
248 CAESAREAN SECTION 45 0.0039
249 PNEUMATOSIS INTESTINALIS 11 0.0039
250 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 19 0.0038
251 ESCHERICHIA SEPSIS 11 0.0038
252 CHRONIC KIDNEY DISEASE 285 0.0037
253 STRIDOR 11 0.0037
254 MATERNAL EXPOSURE TIMING UNSPECIFIED 14 0.0037
255 GUILLAIN-BARRE SYNDROME 18 0.0037
256 LYMPHOCYTOSIS 8 0.0037
257 CONJUNCTIVAL HYPERAEMIA 13 0.0036
258 ESCHERICHIA INFECTION 30 0.0036
259 TENDERNESS 38 0.0036
260 INTESTINAL ISCHAEMIA 20 0.0036
261 CLEFT PALATE 7 0.0036
262 EXPOSURE DURING BREAST FEEDING 12 0.0036
263 SEPTIC SHOCK 157 0.0036
264 TACHYARRHYTHMIA 9 0.0036
265 ENDOTRACHEAL INTUBATION 10 0.0036
266 LEFT VENTRICULAR HYPERTROPHY 15 0.0035
267 CANDIDIASIS 14 0.0035
268 DEVICE RELATED SEPSIS 7 0.0035
269 FUNGAL SKIN INFECTION 14 0.0035
270 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
271 URINE OUTPUT DECREASED 30 0.0034
272 PANCREATITIS CHRONIC 8 0.0034
273 GASTROINTESTINAL PERFORATION 14 0.0034
274 HYPOSPADIAS 7 0.0034
275 HYPERLACTACIDAEMIA 9 0.0034
276 TORSADE DE POINTES 26 0.0033
277 HYPERBILIRUBINAEMIA 34 0.0033
278 VENTRICULAR EXTRASYSTOLES 34 0.0033
279 HEPARIN-INDUCED THROMBOCYTOPENIA 16 0.0032
280 HYPERNATRAEMIA 16 0.0032
281 DISSEMINATED INTRAVASCULAR COAGULATION 45 0.0032
282 METABOLIC ACIDOSIS 101 0.0032
283 ACIDOSIS 24 0.0031
284 NORMAL NEWBORN 17 0.0031
285 BONE LESION 11 0.0030
286 CARDIAC MURMUR 26 0.0030
287 AREFLEXIA 8 0.0030
288 ACUTE RESPIRATORY DISTRESS SYNDROME 53 0.0030
289 NEPHRITIS 10 0.0030
290 EXPOSURE DURING PREGNANCY 186 0.0030
291 FOETAL GROWTH RESTRICTION 18 0.0030
292 PERIPHERAL ISCHAEMIA 12 0.0029
293 CARDIOMEGALY 36 0.0029
294 STREPTOCOCCAL INFECTION 16 0.0029
295 NECROSIS 16 0.0029
296 NECROTISING FASCIITIS 10 0.0028
297 EYE INFLAMMATION 27 0.0028
298 ORTHOPNOEA 9 0.0028
299 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
300 NEUTROPHILIA 16 0.0028
301 PNEUMONIA FUNGAL 11 0.0028
302 HEPATIC LESION 12 0.0028
303 HYPOTHERMIA 28 0.0028
304 DRUG ERUPTION 49 0.0028
305 TOXIC ENCEPHALOPATHY 14 0.0028
306 GENERALISED OEDEMA 34 0.0027
307 MITRAL VALVE INCOMPETENCE 31 0.0027
308 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
309 ECONOMIC PROBLEM 41 0.0027
310 ENCEPHALOPATHY 66 0.0027
311 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
312 PHOTOPHOBIA 50 0.0027
313 VASCULAR DEVICE INFECTION 12 0.0026
314 RESPIRATORY DISTRESS 73 0.0026
315 EOSINOPHILIA 46 0.0026
316 HAEMODYNAMIC INSTABILITY 20 0.0026
317 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
318 LUNG INFILTRATION 23 0.0026
319 RHINOVIRUS INFECTION 10 0.0026
320 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 19 0.0025
321 GESTATIONAL DIABETES 12 0.0025
322 FAILURE TO THRIVE 13 0.0025
323 SARS-COV-2 TEST POSITIVE 33 0.0025
324 CYTOMEGALOVIRUS INFECTION REACTIVATION 11 0.0025
325 ORGAN FAILURE 10 0.0025
326 VENTRICULAR ARRHYTHMIA 9 0.0025
327 ANHEDONIA 64 0.0024
328 DEAFNESS NEUROSENSORY 8 0.0024
329 VENTRICULAR FIBRILLATION 27 0.0024
330 STEVENS-JOHNSON SYNDROME 54 0.0024
331 PYELONEPHRITIS 21 0.0024
332 CHOLANGITIS 15 0.0024
333 PNEUMONIA BACTERIAL 22 0.0024
334 HEPATIC NECROSIS 9 0.0024
335 RENAL FAILURE 316 0.0024
336 WOUND DEHISCENCE 8 0.0024
337 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
338 CIRCULATORY COLLAPSE 40 0.0023
339 HEPATOMEGALY 23 0.0023
340 DEVICE RELATED INFECTION 36 0.0023
341 DECUBITUS ULCER 19 0.0023
342 ANURIA 20 0.0023
343 SPINAL CORD COMPRESSION 9 0.0023
344 OSTEOPENIA 35 0.0023
345 MASTICATION DISORDER 7 0.0023
346 OEDEMA 124 0.0023
347 BRAIN DEATH 7 0.0023
348 MYOCLONUS 27 0.0023
349 RENAL INJURY 67 0.0023
350 ENTEROCOLITIS 13 0.0022
351 STAPHYLOCOCCAL SEPSIS 11 0.0022
352 ADRENAL INSUFFICIENCY 27 0.0022
353 SMALL FOR DATES BABY 11 0.0022
354 CONGENITAL ANOMALY 17 0.0022
355 THROMBOCYTOSIS 8 0.0022
356 LOOSE TOOTH 7 0.0022
357 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
358 UROSEPSIS 20 0.0022
359 BLOOD PRESSURE DIASTOLIC INCREASED 10 0.0022
360 SPINAL OSTEOARTHRITIS 19 0.0022
361 PULMONARY HYPERTENSION 45 0.0022
362 ACUTE KIDNEY INJURY 330 0.0022
363 HEPATOTOXICITY 48 0.0022
364 PNEUMOTHORAX 34 0.0021
365 INTESTINAL PERFORATION 24 0.0021
366 INTESTINAL STENOSIS 9 0.0021
367 TACHYPNOEA 29 0.0021
368 SKIN NECROSIS 11 0.0021
369 DEVELOPMENTAL DELAY 19 0.0021
370 SUBCUTANEOUS ABSCESS 10 0.0021
371 METASTASES TO SPINE 7 0.0021
372 MULTI-ORGAN FAILURE 36 0.0021
373 SPINAL COMPRESSION FRACTURE 17 0.0021
374 INTERVERTEBRAL DISC DEGENERATION 19 0.0021
375 COAGULOPATHY 34 0.0020
376 BREATH SOUNDS ABNORMAL 10 0.0020
377 ILEUS PARALYTIC 9 0.0020
378 HYPERREFLEXIA 7 0.0020
379 DRUG EXPOSURE DURING PREGNANCY 68 0.0020
380 JOINT DISLOCATION 21 0.0020
381 SEPSIS 221 0.0020
382 PATHOLOGICAL FRACTURE 10 0.0020
383 SINUS BRADYCARDIA 19 0.0020
384 RENAL TUBULAR NECROSIS 19 0.0019
385 GENERALISED TONIC-CLONIC SEIZURE 32 0.0019
386 CARDIAC VALVE DISEASE 11 0.0019
387 ANAPHYLACTIC REACTION 106 0.0019
388 BLOOD PHOSPHORUS DECREASED 7 0.0019
389 HYPOKALAEMIA 88 0.0019
390 SINUS TACHYCARDIA 27 0.0019
391 AMYLASE INCREASED 7 0.0019
392 HYDRONEPHROSIS 14 0.0019
393 HYPOMAGNESAEMIA 26 0.0019
394 CYTOMEGALOVIRUS INFECTION 31 0.0019
395 ATAXIA 22 0.0019
396 EAR PAIN 36 0.0018
397 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
398 ENDOPHTHALMITIS 11 0.0018
399 COMMUNICATION DISORDER 7 0.0018
400 BACTERIAL INFECTION 34 0.0018
401 OSTEOMYELITIS 33 0.0018
402 HYPERVOLAEMIA 9 0.0018
403 RENAL FAILURE CHRONIC 14 0.0018
404 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
405 MENTAL STATUS CHANGES 50 0.0018
406 DERMATITIS BULLOUS 13 0.0018
407 CARDIOPULMONARY FAILURE 7 0.0018
408 SCOLIOSIS 11 0.0018
409 EXPOSURE VIA BREAST MILK 7 0.0018
410 PHLEBITIS 9 0.0018
411 NEUROLOGICAL SYMPTOM 10 0.0017
412 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
413 RESPIRATORY FAILURE 127 0.0017
414 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
415 PLEURAL EFFUSION 105 0.0017
416 HYPERTHERMIA 13 0.0017
417 VAGINAL INFECTION 8 0.0017
418 DIVERTICULUM 12 0.0017
419 DRUG WITHDRAWAL SYNDROME NEONATAL 25 0.0017
420 ACUTE HEPATIC FAILURE 23 0.0017
421 BLOOD UREA INCREASED 28 0.0017
422 KIDNEY TRANSPLANT REJECTION 8 0.0017
423 BRAIN OEDEMA 21 0.0017
424 ORAL PAIN 37 0.0017
425 CHOLECYSTITIS CHRONIC 11 0.0016
426 BLOOD ALBUMIN DECREASED 13 0.0016
427 BLOOD MAGNESIUM DECREASED 14 0.0016
428 POLYURIA 13 0.0016
429 POLYNEUROPATHY 19 0.0016
430 ABDOMINAL ABSCESS 7 0.0016
431 ABSCESS 25 0.0016
432 HYPOALBUMINAEMIA 12 0.0015
433 HYPOGAMMAGLOBULINAEMIA 10 0.0015
434 RENAL CYST 12 0.0015
435 CHOLECYSTITIS 18 0.0015
436 DERMATITIS ALLERGIC 19 0.0015
437 THINKING ABNORMAL 28 0.0015
438 CARDIAC FAILURE ACUTE 10 0.0015
439 TOOTH LOSS 31 0.0015
440 OSTEONECROSIS OF JAW 37 0.0015
441 BRADYCARDIA 79 0.0015
442 ELECTROLYTE IMBALANCE 17 0.0015
443 OSTEOARTHRITIS 62 0.0015
444 VASCULITIS 17 0.0015
445 NEPHROTIC SYNDROME 10 0.0015
446 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
447 BONE DENSITY DECREASED 45 0.0014
448 NEUROLEPTIC MALIGNANT SYNDROME 17 0.0014
449 ASCITES 42 0.0014
450 SNEEZING 32 0.0014
451 NEPHROPATHY TOXIC 16 0.0014
452 HYPERLIPIDAEMIA 17 0.0014
453 ABDOMINAL TENDERNESS 7 0.0014
454 IRON DEFICIENCY ANAEMIA 13 0.0014
455 GRAND MAL CONVULSION 13 0.0014
456 DERMATITIS EXFOLIATIVE 7 0.0014
457 CARDIOGENIC SHOCK 20 0.0014
458 ERYSIPELAS 7 0.0014
459 NEPHROPATHY 13 0.0014
460 ARTERIOSCLEROSIS 13 0.0014
461 DYSLIPIDAEMIA 7 0.0014
462 CEREBRAL ISCHAEMIA 7 0.0014
463 WOUND 38 0.0014
464 SEROTONIN SYNDROME 26 0.0014
465 LYMPHOPENIA 19 0.0013
466 RENAL FAILURE ACUTE 57 0.0013
467 PETECHIAE 14 0.0013
468 HAEMORRHAGE INTRACRANIAL 20 0.0013
469 BONE LOSS 20 0.0013
470 DRUG LEVEL INCREASED 22 0.0013
471 BLOOD LACTIC ACID INCREASED 7 0.0013
472 INGUINAL HERNIA 8 0.0013
473 EXOSTOSIS 12 0.0013
474 ECCHYMOSIS 9 0.0013
475 RESPIRATORY DISORDER 39 0.0013
476 ACUTE RESPIRATORY FAILURE 25 0.0013
477 ANAL ABSCESS 7 0.0013
478 HYPERCALCAEMIA 16 0.0013
479 TACHYCARDIA 115 0.0013
480 INFUSION SITE EXTRAVASATION 8 0.0013
481 SUBARACHNOID HAEMORRHAGE 13 0.0013
482 DUODENAL ULCER 9 0.0013
483 BLOOD CREATININE INCREASED 83 0.0013
484 NEUTROPHIL COUNT INCREASED 13 0.0013
485 SHOCK 29 0.0013
486 HEPATIC FAILURE 38 0.0013
487 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 69 0.0013
488 IMMUNOSUPPRESSION 11 0.0012
489 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
490 LEUKOPENIA 62 0.0012
491 DELIRIUM 43 0.0012
492 AGRANULOCYTOSIS 23 0.0012
493 C-REACTIVE PROTEIN INCREASED 45 0.0012
494 RASH PUSTULAR 9 0.0012
495 HAEMOLYTIC ANAEMIA 11 0.0012
496 HYPOPHOSPHATAEMIA 9 0.0012
497 THROMBOCYTOPENIA 136 0.0012
498 HYPOCALCAEMIA 23 0.0012
499 ILEUS 15 0.0012
500 RETINAL DETACHMENT 11 0.0012
501 HYPOGLYCAEMIA 58 0.0012
502 TOXIC SKIN ERUPTION 12 0.0012
503 ERYTHEMA MULTIFORME 11 0.0012
504 DEFORMITY 11 0.0012
505 DENTAL CARIES 13 0.0012
506 BLOOD POTASSIUM INCREASED 19 0.0012
507 HAEMATURIA 40 0.0012
508 PERICARDIAL EFFUSION 27 0.0012
509 STATUS EPILEPTICUS 13 0.0011
510 CYANOSIS 18 0.0011
511 RESPIRATORY DEPRESSION 14 0.0011
512 HYPOXIA 40 0.0011
513 PRODUCT USE IN UNAPPROVED INDICATION 281 0.0011
514 CONJUNCTIVITIS 21 0.0011
515 PURPURA 10 0.0011
516 ASPARTATE AMINOTRANSFERASE INCREASED 60 0.0011
517 BRONCHOSPASM 16 0.0011
518 GALLBLADDER DISORDER 20 0.0011
519 BODY TEMPERATURE DECREASED 11 0.0011
520 PERITONITIS 23 0.0011
521 HAEMATOCRIT DECREASED 22 0.0011
522 SLEEP APNOEA SYNDROME 21 0.0011
523 PYREXIA 380 0.0011
524 BONE DISORDER 20 0.0011
525 CHOLESTASIS 21 0.0011
526 PANCYTOPENIA 61 0.0011
527 UNRESPONSIVE TO STIMULI 28 0.0011
528 HEMIPLEGIA 9 0.0011
529 MEDICAL DEVICE COMPLICATION 8 0.0011
530 TOOTH ABSCESS 11 0.0011
531 HERPES SIMPLEX 7 0.0011
532 HEPATITIS ACUTE 7 0.0011
533 BLOOD BILIRUBIN INCREASED 29 0.0011
534 PULMONARY OEDEMA 48 0.0011
535 HAEMODIALYSIS 9 0.0011
536 RENAL IMPAIRMENT 90 0.0011
537 INJURY 75 0.0011
538 DIALYSIS 15 0.0011
539 BLISTER 59 0.0010
540 PARALYSIS 15 0.0010
541 ANAPHYLACTIC SHOCK 27 0.0010
542 HYPOTENSION 206 0.0010
543 SPLENOMEGALY 12 0.0010
544 SKIN DISORDER 34 0.0010
545 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
546 RESPIRATORY RATE INCREASED 9 0.0010
547 INTERSTITIAL LUNG DISEASE 49 0.0010
548 WRONG DRUG ADMINISTERED 9 0.0010
549 INTESTINAL OBSTRUCTION 38 0.0010
550 HEMIPARESIS 17 0.0010
551 STAPHYLOCOCCAL INFECTION 33 0.0010
552 HYPERKALAEMIA 35 0.0010
553 PLATELET COUNT INCREASED 13 0.0010
554 TOOTHACHE 18 0.0010
555 CARDIAC ARREST 82 0.0010
556 RHINITIS 8 0.0010
557 URINARY TRACT INFECTION 169 0.0010
558 HYPERGLYCAEMIA 36 0.0010
559 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
560 HAEMOPTYSIS 27 0.0010
561 SKIN ULCER 25 0.0010
562 FLANK PAIN 9 0.0010
563 ANAEMIA 182 0.0010
564 PAIN IN JAW 27 0.0010
565 OSTEOPOROSIS 39 0.0009
566 COMA 45 0.0009
567 OXYGEN SATURATION DECREASED 53 0.0009
568 HALLUCINATION 71 0.0009
569 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
570 EMOTIONAL DISTRESS 113 0.0009
571 GASTROOESOPHAGEAL REFLUX DISEASE 75 0.0009
572 JAUNDICE 25 0.0009
573 VITAMIN D DEFICIENCY 9 0.0009
574 AORTIC ANEURYSM 7 0.0009
575 CHOLELITHIASIS 30 0.0009
576 METASTASES TO BONE 15 0.0009
577 PHARYNGEAL OEDEMA 14 0.0009
578 ANGIOEDEMA 40 0.0009
579 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
580 CEREBRAL INFARCTION 22 0.0009
581 INFECTION 130 0.0009
582 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
583 NERVOUS SYSTEM DISORDER 28 0.0009
584 DYSPHAGIA 85 0.0009
585 HYPOKINESIA 13 0.0009
586 PROTEINURIA 17 0.0009
587 WHEEZING 53 0.0009
588 CELLULITIS 45 0.0009
589 FEAR 24 0.0009
590 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
591 GASTROENTERITIS 13 0.0009
592 RASH GENERALISED 23 0.0009
593 HEPATIC FUNCTION ABNORMAL 33 0.0009
594 URINARY INCONTINENCE 26 0.0009
595 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
596 PULMONARY MASS 13 0.0009
597 DIVERTICULITIS 24 0.0009
598 METASTASES TO LUNG 10 0.0009
599 POST PROCEDURAL HAEMORRHAGE 10 0.0009
600 MASS 12 0.0009
601 NEUROTOXICITY 15 0.0009
602 METASTASES TO CENTRAL NERVOUS SYSTEM 11 0.0009
603 SKIN REACTION 12 0.0009
604 SPINAL FRACTURE 17 0.0008
605 ALANINE AMINOTRANSFERASE INCREASED 52 0.0008
606 THERAPY NON-RESPONDER 38 0.0008
607 CONDITION AGGRAVATED 257 0.0008
608 PNEUMONIA ASPIRATION 21 0.0008
609 EOSINOPHIL COUNT INCREASED 7 0.0008
610 THROMBOTIC MICROANGIOPATHY 8 0.0008
611 OBESITY 13 0.0008
612 KIDNEY INFECTION 16 0.0008
613 VIRAL INFECTION 27 0.0008
614 CHILLS 95 0.0008
615 FUNGAL INFECTION 27 0.0008
616 PALLOR 22 0.0008
617 MALNUTRITION 9 0.0008
618 NEUTROPENIA 109 0.0008
619 IRRITABILITY 48 0.0008
620 EMPHYSEMA 8 0.0008
621 BONE MARROW FAILURE 16 0.0008
622 CARPAL TUNNEL SYNDROME 11 0.0008
623 POST PROCEDURAL COMPLICATION 15 0.0008
624 CONTUSION 75 0.0008
625 ANAL INCONTINENCE 7 0.0008
626 HIATUS HERNIA 10 0.0008
627 HAEMATOMA 20 0.0008
628 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
629 NECK PAIN 43 0.0008
630 ABDOMINAL DISTENSION 80 0.0008
631 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
632 GENERAL PHYSICAL HEALTH DETERIORATION 88 0.0008
633 CORONARY ARTERY DISEASE 23 0.0008
634 ORAL CANDIDIASIS 10 0.0008
635 MOUTH ULCERATION 16 0.0008
636 TOOTH INFECTION 10 0.0008
637 PULMONARY CONGESTION 10 0.0008
638 PANCREATITIS 40 0.0008
639 FLUID OVERLOAD 11 0.0008
640 BLOOD PRESSURE FLUCTUATION 18 0.0007
641 DIARRHOEA HAEMORRHAGIC 7 0.0007
642 PNEUMONIA 242 0.0007
643 BLOOD SODIUM DECREASED 14 0.0007
644 BLOOD URINE PRESENT 14 0.0007
645 BODY TEMPERATURE INCREASED 15 0.0007
646 SMALL INTESTINAL OBSTRUCTION 9 0.0007
647 MULTIPLE FRACTURES 12 0.0007
648 RHINORRHOEA 47 0.0007
649 CEREBRAL HAEMORRHAGE 26 0.0007
650 HYPERCHOLESTEROLAEMIA 7 0.0007
651 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
652 TRANSAMINASES INCREASED 16 0.0007
653 HYPERTENSIVE CRISIS 8 0.0007
654 HAEMORRHOIDS 14 0.0007
655 INFLAMMATORY BOWEL DISEASE 7 0.0007
656 DYSKINESIA 29 0.0007
657 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
658 LETHARGY 41 0.0007
659 FISTULA 8 0.0007
660 FEBRILE NEUTROPENIA 47 0.0007
661 AGITATION 52 0.0007
662 EJECTION FRACTION DECREASED 11 0.0007
663 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
664 HYPONATRAEMIA 39 0.0007
665 DRUG INTERACTION 109 0.0007
666 COLITIS 26 0.0007
667 RESTLESSNESS 25 0.0007
668 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
669 DYSURIA 25 0.0007
670 LYMPHADENOPATHY 24 0.0007
671 CARDIOMYOPATHY 10 0.0007
672 JOINT RANGE OF MOTION DECREASED 9 0.0007
673 OSTEONECROSIS 22 0.0007
674 VENTRICULAR TACHYCARDIA 11 0.0007
675 ORAL HERPES 13 0.0007
676 DRUG INEFFECTIVE 876 0.0007
677 HEPATITIS 17 0.0007
678 CONFUSIONAL STATE 107 0.0007
679 IMPAIRED GASTRIC EMPTYING 9 0.0007
680 MENTAL IMPAIRMENT 16 0.0007
681 BURSITIS 8 0.0007
682 INFLAMMATION 34 0.0007
683 SKIN LESION 18 0.0007
684 PERIPHERAL COLDNESS 9 0.0007
685 NEPHROLITHIASIS 30 0.0007
686 FACE OEDEMA 11 0.0007
687 LIVER INJURY 16 0.0007
688 PREGNANCY 13 0.0006
689 LACTIC ACIDOSIS 21 0.0006
690 CARDIAC FAILURE 52 0.0006
691 DEEP VEIN THROMBOSIS 42 0.0006
692 PHARYNGITIS 8 0.0006
693 ASPIRATION 7 0.0006
694 RASH 276 0.0006
695 PRODUCT PREPARATION ERROR 13 0.0006
696 ABDOMINAL PAIN LOWER 16 0.0006
697 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
698 HEPATIC ENZYME INCREASED 43 0.0006
699 APHASIA 19 0.0006
700 SUBDURAL HAEMATOMA 9 0.0006
701 ABDOMINAL PAIN 146 0.0006
702 HEPATIC CYTOLYSIS 8 0.0006
703 GLAUCOMA 12 0.0006
704 GENITAL HAEMORRHAGE 8 0.0006
705 HYPERTHYROIDISM 9 0.0006
706 OEDEMA PERIPHERAL 75 0.0006
707 CONVULSION 35 0.0006
708 MUCOSAL INFLAMMATION 16 0.0006
709 GASTRIC HAEMORRHAGE 7 0.0006
710 GASTRITIS 16 0.0006
711 GAIT DISTURBANCE 116 0.0006
712 BLOOD POTASSIUM DECREASED 18 0.0006
713 HAEMATOCHEZIA 33 0.0006
714 HYPOAESTHESIA ORAL 9 0.0006
715 QUALITY OF LIFE DECREASED 8 0.0006
716 HAEMOGLOBIN DECREASED 61 0.0006
717 MEDICATION ERROR 33 0.0006
718 COVID-19 PNEUMONIA 7 0.0006
719 CHEST PAIN 109 0.0006
720 GINGIVAL BLEEDING 8 0.0006
721 RASH ERYTHEMATOUS 28 0.0006
722 CARDIAC FAILURE CONGESTIVE 47 0.0006
723 DEHYDRATION 78 0.0006
724 RENAL DISORDER 27 0.0006
725 LUNG INFECTION 9 0.0006
726 URTICARIA 97 0.0006
727 PULMONARY EMBOLISM 55 0.0006
728 RESPIRATORY TRACT INFECTION 15 0.0006
729 ABORTION SPONTANEOUS 23 0.0006
730 CARDIO-RESPIRATORY ARREST 24 0.0006
731 DEAFNESS 15 0.0006
732 ANXIETY 162 0.0006
733 ERYTHEMA 117 0.0006
734 SLEEP DISORDER 40 0.0006
735 ATRIAL FIBRILLATION 55 0.0006
736 RETCHING 12 0.0006
737 SEIZURE 65 0.0006
738 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
739 TREATMENT FAILURE 46 0.0006
740 PLATELET COUNT DECREASED 59 0.0006
741 LUNG DISORDER 27 0.0006
742 PELVIC PAIN 10 0.0005
743 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
744 IMPAIRED HEALING 18 0.0005
745 MUSCULOSKELETAL STIFFNESS 48 0.0005
746 HYPOPHAGIA 14 0.0005
747 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
748 RECTAL HAEMORRHAGE 23 0.0005
749 THROMBOSIS 43 0.0005
750 HYPOTHYROIDISM 17 0.0005
751 LOSS OF CONSCIOUSNESS 68 0.0005
752 DERMATITIS 11 0.0005
753 PRODUCTIVE COUGH 25 0.0005
754 ORTHOSTATIC HYPOTENSION 9 0.0005
755 EATING DISORDER 11 0.0005
756 DELUSION 8 0.0005
757 GASTRIC CANCER 13 0.0005
758 IRRITABLE BOWEL SYNDROME 11 0.0005
759 INFUSION RELATED REACTION 34 0.0005
760 BLOOD PRESSURE DECREASED 34 0.0005
761 POOR QUALITY SLEEP 11 0.0005
762 URINARY RETENTION 17 0.0005
763 LYMPHOCYTE COUNT DECREASED 9 0.0005
764 HYPERTENSION 107 0.0005
765 TYPE 2 DIABETES MELLITUS 17 0.0005
766 OFF LABEL USE 441 0.0005
767 STOMATITIS 30 0.0005
768 BLOOD CHOLESTEROL INCREASED 23 0.0005
769 NEUTROPHIL COUNT DECREASED 20 0.0005
770 ANGINA PECTORIS 14 0.0005
771 HYPOAESTHESIA 73 0.0005
772 RIB FRACTURE 10 0.0005
773 ARRHYTHMIA 23 0.0005
774 HEPATIC STEATOSIS 9 0.0005
775 BACK PAIN 112 0.0005
776 ABNORMAL BEHAVIOUR 19 0.0005
777 DYSSTASIA 14 0.0005
778 CONSTIPATION 104 0.0005
779 HALLUCINATION, VISUAL 10 0.0005
780 SCAR 8 0.0005
781 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
782 TOXICITY TO VARIOUS AGENTS 77 0.0005
783 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
784 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
785 DYSPNOEA EXERTIONAL 17 0.0005
786 LIVER DISORDER 20 0.0005
787 TOOTH DISORDER 10 0.0004
788 PRODUCT ADMINISTRATION ERROR 9 0.0004
789 VISUAL IMPAIRMENT 55 0.0004
790 CHROMATURIA 10 0.0004
791 WEIGHT DECREASED 123 0.0004
792 MUSCULAR WEAKNESS 50 0.0004
793 DYSPNOEA 249 0.0004
794 CYSTITIS 14 0.0004
795 DISEASE PROGRESSION 52 0.0004
796 SPEECH DISORDER 23 0.0004
797 HEART RATE INCREASED 43 0.0004
798 CARDIOVASCULAR DISORDER 11 0.0004
799 VOMITING 200 0.0004
800 PAIN 261 0.0004
801 EMOTIONAL DISORDER 13 0.0004
802 COUGH 118 0.0004
803 ASTHENIA 158 0.0004
804 MUSCULOSKELETAL PAIN 22 0.0004
805 LIVER FUNCTION TEST INCREASED 9 0.0004
806 SWOLLEN TONGUE 13 0.0004
807 HYPERSENSITIVITY 77 0.0004
808 DRUG-INDUCED LIVER INJURY 13 0.0004
809 DEPRESSION 94 0.0004
810 CRYING 15 0.0004
811 VERTIGO 25 0.0004
812 DECREASED APPETITE 94 0.0004
813 HAEMORRHAGE 42 0.0004
814 RASH PAPULAR 9 0.0004
815 DISEASE RECURRENCE 19 0.0004
816 SWELLING 37 0.0004
817 DIABETES MELLITUS 30 0.0004
818 EPILEPSY 12 0.0004
819 ISCHAEMIC STROKE 7 0.0004
820 BRONCHITIS 29 0.0004
821 SKIN DISCOLOURATION 18 0.0004
822 DRUG INTOLERANCE 37 0.0004
823 MYALGIA 65 0.0004
824 BALANCE DISORDER 33 0.0004
825 JOINT SWELLING 46 0.0004
826 TREMOR 63 0.0004
827 HEPATIC CIRRHOSIS 7 0.0004
828 DYSARTHRIA 14 0.0004
829 UNEVALUABLE EVENT 28 0.0004
830 PRURITUS GENERALISED 8 0.0004
831 DIARRHOEA 238 0.0004
832 PNEUMONITIS 10 0.0004
833 PRODUCT PRESCRIBING ISSUE 8 0.0004
834 DRUG PRESCRIBING ERROR 7 0.0004
835 VISUAL ACUITY REDUCED 12 0.0004
836 RHEUMATOID ARTHRITIS 41 0.0004
837 RHABDOMYOLYSIS 15 0.0004
838 POLLAKIURIA 15 0.0004
839 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
840 DEMENTIA 10 0.0004
841 PANIC ATTACK 13 0.0004
842 DISORIENTATION 14 0.0004
843 CATARACT 21 0.0004
844 RED BLOOD CELL COUNT DECREASED 10 0.0003
845 HEART RATE DECREASED 12 0.0003
846 BONE PAIN 20 0.0003
847 ACUTE MYOCARDIAL INFARCTION 10 0.0003
848 PSYCHOTIC DISORDER 10 0.0003
849 SWELLING FACE 22 0.0003
850 EYE DISORDER 11 0.0003
851 PLASMA CELL MYELOMA 13 0.0003
852 RASH PRURITIC 18 0.0003
853 INFLUENZA 37 0.0003
854 PRESYNCOPE 8 0.0003
855 ABDOMINAL DISCOMFORT 55 0.0003
856 RESPIRATORY ARREST 9 0.0003
857 NEUROPATHY PERIPHERAL 31 0.0003
858 ABASIA 8 0.0003
859 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
860 COGNITIVE DISORDER 15 0.0003
861 AGEUSIA 8 0.0003
862 CEREBROVASCULAR ACCIDENT 54 0.0003
863 HEAD INJURY 10 0.0003
864 THROAT IRRITATION 14 0.0003
865 HEART RATE IRREGULAR 7 0.0003
866 LIVER FUNCTION TEST ABNORMAL 9 0.0003
867 NAUSEA 244 0.0003
868 NASAL CONGESTION 18 0.0003
869 TINNITUS 14 0.0003
870 HYPOACUSIS 13 0.0003
871 EAR INFECTION 8 0.0003
872 FALL 99 0.0003
873 PRURITUS 114 0.0003
874 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
875 DISCOMFORT 18 0.0003
876 OCULAR HYPERAEMIA 14 0.0003
877 DIZZINESS 146 0.0003
878 PRODUCT USE ISSUE 55 0.0003
879 LUNG NEOPLASM MALIGNANT 12 0.0003
880 NIGHTMARE 10 0.0003
881 DRY SKIN 38 0.0003
882 WEIGHT INCREASED 63 0.0003
883 EPISTAXIS 21 0.0003
884 MOVEMENT DISORDER 9 0.0003
885 HEADACHE 175 0.0003
886 HYPERSOMNIA 8 0.0003
887 CARDIAC DISORDER 26 0.0003
888 HAEMATEMESIS 7 0.0003
889 ERECTILE DYSFUNCTION 7 0.0003
890 ARTHRALGIA 113 0.0003
891 LABORATORY TEST ABNORMAL 8 0.0003
892 GAIT INABILITY 9 0.0003
893 GASTROINTESTINAL DISORDER 24 0.0003
894 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
895 ANGER 9 0.0003
896 DEPRESSED MOOD 14 0.0003
897 LACRIMATION INCREASED 8 0.0003
898 FLATULENCE 15 0.0003
899 SINUSITIS 27 0.0003
900 FATIGUE 205 0.0003
901 HERPES ZOSTER 15 0.0003
902 ARTHRITIS 20 0.0003
903 COVID-19 44 0.0003
904 MOBILITY DECREASED 18 0.0003
905 SYNCOPE 25 0.0002
906 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
907 SOMNOLENCE 50 0.0002
908 NIGHT SWEATS 8 0.0002
909 ASTHMA 28 0.0002
910 SUICIDE ATTEMPT 15 0.0002
911 NASOPHARYNGITIS 45 0.0002
912 BLOOD PRESSURE INCREASED 37 0.0002
913 EYE SWELLING 9 0.0002
914 DISTURBANCE IN ATTENTION 13 0.0002
915 LIP SWELLING 8 0.0002
916 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
917 FLUID RETENTION 12 0.0002
918 HYPERHIDROSIS 30 0.0002
919 AMNESIA 15 0.0002
920 VAGINAL HAEMORRHAGE 10 0.0002
921 MENTAL DISORDER 10 0.0002
922 ECZEMA 12 0.0002
923 INSOMNIA 61 0.0002
924 ABDOMINAL PAIN UPPER 47 0.0002
925 MYELOSUPPRESSION 8 0.0002
926 INFLUENZA LIKE ILLNESS 18 0.0002
927 HIP FRACTURE 7 0.0002
928 PARAESTHESIA 34 0.0002
929 OROPHARYNGEAL PAIN 20 0.0002
930 CHEST DISCOMFORT 22 0.0002
931 EYE PAIN 12 0.0002
932 PAIN IN EXTREMITY 62 0.0002
933 DEVICE DISLOCATION 9 0.0002
934 TREATMENT NONCOMPLIANCE 11 0.0002
935 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
936 BURNING SENSATION 14 0.0002
937 OVERDOSE 43 0.0002
938 THERAPEUTIC RESPONSE DECREASED 12 0.0002
939 DRY MOUTH 16 0.0002
940 SUICIDAL IDEATION 18 0.0002
941 SKIN IRRITATION 9 0.0002
942 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
943 NO ADVERSE EVENT 35 0.0002
944 SKIN EXFOLIATION 16 0.0002
945 BLOOD GLUCOSE DECREASED 9 0.0002
946 ACNE 14 0.0002
947 AGGRESSION 9 0.0002
948 BLINDNESS 7 0.0002
949 PERIPHERAL SWELLING 26 0.0002
950 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
951 MYOCARDIAL INFARCTION 29 0.0002
952 FEELING HOT 10 0.0002
953 ADVERSE EVENT 15 0.0002
954 ARTHROPATHY 9 0.0002
955 VISION BLURRED 22 0.0002
956 MALAISE 70 0.0002
957 MUSCLE SPASMS 29 0.0002
958 THERAPY CESSATION 8 0.0002
959 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
960 DYSPHONIA 9 0.0002
961 SURGERY 9 0.0002
962 NERVOUSNESS 8 0.0002
963 DEATH 130 0.0002
964 NEOPLASM MALIGNANT 10 0.0001
965 HOT FLUSH 11 0.0001
966 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
967 DRY EYE 7 0.0001
968 MEMORY IMPAIRMENT 19 0.0001
969 DYSPEPSIA 13 0.0001
970 FLUSHING 13 0.0001
971 BLOOD GLUCOSE INCREASED 24 0.0001
972 PRODUCT QUALITY ISSUE 16 0.0001
973 FEELING ABNORMAL 28 0.0001
974 MIGRAINE 11 0.0001
975 ILL-DEFINED DISORDER 7 0.0001
976 ALOPECIA 22 0.0001
977 ADVERSE DRUG REACTION 10 0.0001
978 PALPITATIONS 13 0.0001
979 INTENTIONAL OVERDOSE 7 0.0001
980 PRODUCT DOSE OMISSION ISSUE 31 0.0001
981 HOSPITALISATION 16 0.0001
982 COMPLETED SUICIDE 8 0.0001
983 INTENTIONAL PRODUCT MISUSE 8 0.0001
984 DRUG WITHDRAWAL SYNDROME 8 0.0001
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
986 ILLNESS 9 0.0001
987 INCORRECT DOSE ADMINISTERED 18 0.0001
988 DRUG DOSE OMISSION 13 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
990 INJECTION SITE ERYTHEMA 7 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
992 INJECTION SITE PAIN 10 0.0000